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A B S T R A C T
Although recent advances in seizure anticipation have been achieved with the development of several
biomathematical electroencephalographic (EEG) methods, pre-ictal clinical phenomena have not been
extensively investigated. The aim of the study was to thoroughly analyze premonitory or prodromal
symptoms (PS) in a randomly selected sample of 100 adult epileptic patients. A semi-structured protocol
was used for in-person interviews to both patients and observers. PS were found in 39% of patients, the
most frequent ones being behavioral, cognitive and mood changes. Both patients with focal and
generalized epilepsies reported prodromes, although they were more frequently found in the former
group. PS were mostly perceived preceding complex partial and generalized tonic–clonic seizures.
Prodromal symptoms were reported to have an insidious onset and their duration ranged from 30 min to
several hours. The potential value of prodromes in seizure anticipation would allow the use of preventive
and therapeutic measures, including drugs, neurostimulation procedures and behavioral intervention.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Epilepsy is one of the most common neurological disorders,
with a prevalence that exceeds 1% worldwide. These patients’
quality of life tends to be impaired, not only due to social stigma
and the increased risk of injury and sudden unexpected death,
but also because of the unpredictability of seizures. The
possibility of forecasting the occurrence of seizures, through
the recognition of events taking place during the pre-ictal phase,
would obviously have a positive impact on treatment efﬁcacy
and quality of life.
In recent years, advances in this ﬁeld have been achieved thanks
to various quantiﬁed electroencephalographic (EEG) studies.1–6
However, the clinical phenomena occurring during this pre-ictal
period, i.e. prodromal symptoms (PS) or prodromes, have not been
extensively investigated. There are early references to the subject
7–9 and a few studies have reported mainly on frequency and type
of symptoms using different approaches.10–13 A prospective survey
assessing patients’ seizure self-prediction has been recently* Corresponding author. Tel.: +598 2 7120168; fax: +598 2 4874080.
E-mail address: scaram@adinet.com.uy (A. Scaramelli).
1059-1311/$ – see front matter  2008 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2008.10.007published.14 Amore detailed description of clinical changes during
this period15,16 has been followed by a neurophenomenological
approach to symptoms preceding seizures in 9 patients.17 A better
knowledge of these prodromal or premonitory symptoms would
open a ‘‘clinical window’’ to pre-ictal phenomenology and seizure
prediction.
The aim of this study was to analyze pre-ictal events from a
clinical point of view. Speciﬁc objectives were: (i) to describe the
prevalence and quality of prodromal symptoms in the study
population, (ii) to analyze the association between prodromes and
several variables such as age, sex, seizure type and frequency,
epilepsy syndrome and comorbidities.
2. Material and methods
2.1. Population
Patients with deﬁnite diagnosis of epilepsy, either partial or
generalized, older than 14 years were considered for the study.
Exclusion criteria were: (1) severe mental retardation (unless a
reliable observer was available) and (2) coexistence of non-
epileptic seizures, whenever it was difﬁcult to clearly distinguish
between both types of episodes.vier Ltd. All rights reserved.
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100 patientswere selected through a systematic sampling from the
population of outpatients assisted by the authors between
November 15, 2004 and February 15, 2005.
2.2. Methods
Prodromes were operationally deﬁned as signs or symptoms,
perceived by the patient and/or observer as premonitory,
appearing up to 24 h preceding seizure onset.
Auras, here understood as those subjective symptoms occurring
at the start of a seizure and lasting less than 15 min, were
speciﬁcally excluded.
In-person interviews were performed in all patients and
available observers using a semi-structured protocol, beginning
with an open question: ‘‘is there anything, during the preceding
24 h, that announces that you (he/she) will have a seizure?’’
Subsequently, a pre-established questionnaire, including spe-
ciﬁc questions on potential PS (Fig. 1), was applied.
For each PS reported, information on detailed semiological
description, duration, time to seizure and associated seizure type,
was retrospectively collected. Data on seizure frequency were
obtained from seizure diaries.
Patients and observers who reported cognitive, behavioral and/
or mood changes as a putative PS were asked to describe those
phenomena in detail, and they were referred to an additional
interview performed by our group’s psychiatrist (T.M.).
Information on age, sex, epilepsy syndrome, seizure type and
frequency, duration of epilepsy, history of psychiatric disturbances
and treatmentwas also collected. Association between each PS and
different clinical variables was investigated through chi-square
and T test, applied to string and quantitative measures respec-
tively, with a 0.05 signiﬁcance level.Fig. 1. Prodromal sympto3. Results
3.1. Demographic data
One hundred patients (60 females, 40males)with amean age of
32  13 years, were enrolled. Distribution by epileptic syndromes,
according to the international classiﬁcation 18 showed 77 partial
epilepsies (35 symptomatic, 42 cryptogenic) and 23 generalized
epilepsies (18 idiopathic, one symptomatic and four cryptogenic).
Regarding seizure type,19 of the 77 patients with focal epilepsies, 59
had generalized tonic–clonic seizures (GTCS), 51 had simple partial
seizures (SPS) and 43 reported complex partial seizures (CPS). All the
23 patients with generalized epilepsies had GTCS; 13 patients also
had myoclonic jerks and 5 presented with associated absence
seizures.
Mean duration of epilepsy was 17.8  14 years.
Half the patients (50) had a seizure frequency<6 year; 47 had a
higher frequency, whereas in three cases this information could
not be accurately obtained.
At the time of interview, 52 patients were on monotherapy
(Phenytoin 34, Carbamazepine 18, Valproate 9 and Clonazepam 1),
32were receiving polytherapy and six patientswere offmedication.
Sixty-seven patients had no cognitive impairment; 29 had mild
cognitive deﬁcits, and relevant mental retardation was present in
four cases. Thirteen patients revealed an associated history of
psychiatric disturbances, particularly depression. No other rele-
vant co-morbidity was consistently found in this population.
3.2. Prevalence of prodromal symptoms
Prodromal symptoms were found in 39 out of 100 patients.
Concerning the number of PS evoked in each patient, 18
revealed one PS, 14 identiﬁed two PS, and seven patients referredms—questionnaire.
Table 1
Type and frequencies of reported prodromal symptoms (PS) in the study
population.
Type of PS N
Behavioral changes 13
Cognitive disturbances 11
Anxiety and mood changes 9
Fatigue 7
Sleep disturbances 7
Dysthermia 6
Speech disturbances 4
Voiding changes 4
Gastrointestinal symptoms 3
Headache 2
Changes in appetite 2
Paresthesias 1
Pain (other than headache) 1
Other 5
Total 75
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patients.
PS were identiﬁed, either by the patient or an observer, in
response to the open question, in 29 cases.
3.3. Description of PS
The type of reported PS and their frequencies are shown in
Table 1.
As shown in this table, themost frequently reported prodromes
pertain to the neuropsychiatric domain: behavioral, cognitive and
mood changes. Below is a more detailed description of these three
main categories based on the semiological characteristics collected
through the initial questionnaire and on the subsequent psychia-
tric interview.
3.3.1. Behavioral changes
They were similarly described by all patients and observers,
being basically characterized by irritability and decreased toler-
ance, lasting several hours. Some expressions used by patients
were: ‘‘Several hours before I have a seizure I can’t stand myself’’
(Patient 49); ‘‘I easily get angry and I am in bad temper; I cry easily.
This lasts between approximately 4 h and a whole day, and it
disappears when I have a seizure’’ (Patient 64). Examples of
expressions used by observers were: ‘‘He is normally in good
temper, but a few hours before he has a seizure, he looks upset and
is irascible’’ (Patient 40). ‘‘. . . he responds angrily to everything’’
(Patient 66). This type of prodrome was referred as the single
premonitory symptom in 5 out of 13 patients. It was found to be
overlapped to fatigue in two patients and to changes in appetite in
one patient. Two patients presented previous psychiatric history.
3.3.2. Cognitive disturbances
The description of these symptoms was also quite homo-
geneous: bradipsychia, increased latency in verbal and motor
responses, clumsiness, short-term memory and attention dis-
turbances were the most frequently evoked manifestations.
Some patients referred: ‘‘I have the feeling of slow thinking and I
have to think everything twice; I can’t remember what I have to
do. It seems as if my mind were in slow motion’’ (Patient 83).
‘‘Sometimes, I may intend to go to the bathroom and end up in
my bedroom’’ (Patient 12); ‘‘I want to do something and I can’t. I
keep walking around and don’t manage to do anything’’ (Patient
49). Some quotations from observers were: ‘‘She shows
indecision and slowness; . . .that day we were too late’’ (Patient
34). ‘‘During those hours, nobody knows what she wants to do’’(Patient 25). Only one patient presented a different proﬁle:
sensation of fast thinking, beginning a few hours prior to a
seizure (Patient 31).
3.3.3. Anxiety/mood changes
This group of symptoms included tension, uneasiness or,
alternatively, sadness, apathy and indifference. Quoting patients
and observers: ‘‘I don’t care about anything and I don’t want to do
anything’’ (Patient 61). ‘‘I ammore sensitive than usually; I feel like
crying without any reason’’ (Patient 8). ‘‘I have a mixed feeling of
distress and joy; at the same time I have the sensation that
something is going to occur’’ (Patient 70). This patient’s husband
expressed: ‘‘She is always made-up and well-dressed; the day she
isn’t, we know she’s going to have a ﬁt’’. ‘‘Several hours before a
seizure she is blue and she says she doesn’t know why’’ (Patient
48). Elation was reported in only one case (Patient 13). None of
these patients had a psychiatric history.
3.3.4. Other less frequently reported prodromes
Fatigue: It was mainly referred as a physical complaint, being
sometimes described as lack of energy. Usually, fatigue was
noticed a few hours before either partial or generalized seizures. It
was described in association with behavioral changes (in three out
of seven cases), dysthermic sensation (3/7) and cognitive
disturbances (2/7).
Sleep disturbances: In this group, all patients but one reported
excessive day somnolence, frequently requiring the interruption of
activities in order to sleep. The remaining patient referred
‘‘difﬁculties in getting asleep’’ the night preceding a generalized
tonic–clonic seizure.
Dysthermia: Four patients reported a subjective unusual and
unexplained cold sensation announcing their seizures. Another
patient reported feeling hot. The remaining patient reported
coldness followed by a hot sensation with excessive sweating
lasting about 20 min, occurring 2–3 h before a seizure.
Speech disturbances: They consisted of dysarthria and less
frequently anomias. For instance, patient 83 reported ‘‘slurred
speech’’ and patient 16 said: ‘‘People do not understandwhat I say;
they say I speak as if I were drunk’’
Voiding changes: In all cases it was described as an increase in
number and volume of micturitions, lasting several hours prior to
seizures.
Gastrointestinal symptoms: Two patients referred diarrhea and
one reported vomiting, during a period of a few hours.
Headache: Only two patients mentioned headache within the
period deﬁned as prodromal. One of them had hemicraneal
cephalalgia and vomiting, but he was free of interictal migraine.
Changes in appetite: Both patients reporting this symptom had
an increased appetite. Patient 64 put it into these terms: ‘‘For about
6–8 h and until the seizure begins, I am terribly hungry, much
more than usually’’.
Two patients referred pallor a few hours preceding seizure
onset.
Concerning time of occurrence, PS appeared in a variable period
of time (generally several hours) before seizure onset, within the
operationally deﬁned time window. Thirty percent of prodromes
appeared less than 6 h prior to seizure emergence. Five percent of
PS may have started even before the deﬁned time window, i.e. 24–
48 h prior to seizure onset. No association was found between
prodrome type and delay to seizure occurrence.
Prodromes were mainly perceived as insidious changes rather
than symptoms of abrupt onset or clear-cut temporal limits. Their
duration ranged from 30 min to several hours; 50% of patients
speciﬁed that these symptoms used to last up to the following
seizure.
Table 2
Type ofmost frequently reported prodromal symptoms (PS) according to the source
of information.
Type of PS Patient
only
Patient and
Observer
Observer
only
Behavioral changes 4 1 7
Cognitive disturbances 4 0 6
Anxiety/mood changes 3 3 2
Fatigue 4 1 1
Sleep disturbances 2 0 3
Speech disturbances 2 2 0
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exclusively claimed by an observer in 12 patients, while in 27 cases
they were recalled by the patient him/herself or both by patient
and observer. We did not ﬁnd a statistically signiﬁcant difference
between the type of PS identiﬁed by patients themselves and those
described by observers (Table 2). Nevertheless, most cases of either
fatigue or speech disturbances were noticed predominantly by the
patient, while behavioral changes were more frequently reported
by observers.
3.4. Relationship between prodromes and different variables
Patients with a relatively high frequency of seizures reported PS
more frequently than those with a better seizure control (x2;
p = 0.006).
In general, there was no association between seizure type and
type of PS recalled. However, in the subgroup of patients reporting
cognitive disturbances as PS, these symptoms usually preceded a
generalized tonic–clonic seizure (9 out of 11 cases).
Among patients with GTC seizures, 32.9% reported prodromal
symptoms preceding such type of seizures. This occurred in 32.6%
of those with CPS, and in 7.6% of those with myoclonic seizures.
Only 3.9% referred prodromes before their SPS and none preceding
their absence seizures. These differences were statistically
signiﬁcant (x2, 4DF; p = 0.00037).
Prodromes were more frequently evoked in patients with
partial epilepsies (42%) as compared with those with idiopathic
generalized epilepsies (IGE) (26%), without reaching statistical
signiﬁcance (x2; p = 0.2).
Although the group of IGE patients is too small for statistical
analysis, it showed some common features: all subjects reported
more than one PS and they were only noticed by the patient.
Concerning the type of PS recalled, all these IGE patients referred at
least one PS related to neuropsychiatric changes. Other prodromal
symptoms that were more frequently reported in this subpopula-
tion were sleep disturbances and a dysthermic sensation.
None of the 9 patients who experienced pre-ictal mood changes
presented a past medical history of depression or anxiety
disorders.
No statistical differences were found regarding age, sex and
disease duration between the group that reported PS and the one
that did not.
4. Discussion
In a context of scarce investigations focusing on the clinical
changes preceding seizure onset, our study intends to contribute to
the clinical characterization of this pre-ictal phase.
4.1. Prevalence of prodromal symptoms
Thepercentageofpatients inwhomPSwere identiﬁed (39%) isby
nomeans negligible. Rajna et al.12 reported a ﬁgure of 47%, which isnot comparable since their study included auras. On the other hand,
the prevalence found in our study is higher than that referred by
Giuccioli et al.10 Hughes et al.11 and Schulze-Bonhage et al.13, who
reported 8.6%, 29% and 6.9% respectively. Their lower prevalence
could be due to methodological differences, namely the considera-
tion of the data given only by patients and ‘‘spontaneously’’.
Inclusion of an observer’s anamnesis in the present study increases
the chances of ﬁnding prodromes, while offering an ‘‘objective’’
source of information. If interviews toobservershadnot beenadded,
12% of cases with PS could have remained undetected.
We also found that prodromes were more frequently identiﬁed
in patientswith high seizure frequency. This could be related to the
need of a repetitive experience in order to more easily perceive a
connection between a potential PS and a seizure.
Both patients with focal and generalized epilepsies presented
prodromes, although they were more frequently found in cases
with partial syndromes,whichwould be consistentwith a previous
report. 13
Interestingly, PS were perceivedmore frequently preceding CPS
and GTCS, being rarely reported before other seizure types.
4.2. Type of PS
Concerning the type of PS (Table 1), there is a marked overlap
between our ﬁndings and those reported by most other groups,10–
12,17 thus giving support to ‘‘what happens’’ during the pre-ictal
phase from the clinical point of view. Transcultural homogeneity is
a striking ﬁnding, particularly regarding behavioral symptoms.
Most prodromes belong to the group of neuropsychiatric
modiﬁcations, such as behavioral, mood and cognitive changes.
The subtle nature of these symptoms, in contrast to other more
overt clinical phenomena like motor manifestations, could explain
why the recognition of prodromes has not been so easy, and why
research in this area has not been more extensive in the past.
Among mood changes, depressive symptoms are by far more
frequent than elation symptoms. This is also in accordance with
other authors’ ﬁndings.10–12,16,17,20 Interestingly, such concordant
observations have been made using quite different approaches,
including scales applied during long-term monitoring16 and
phenomenological strategies.17
An increased appetite, polyuria, diarrhea, pallor and/or coldness
were found to be common transitory symptoms associated to
impending seizures. These PS have not been described in other
surveys. Methodological issues, mainly the application of a semi-
structured protocol in our study, speciﬁcally searching for this type
of symptoms, may explain the results.
On the other hand, headaches have not been found to be so
frequent in our study as in other surveys.10–13
The duration of prodromes in this population was reported to
be quite prolonged. This fact not only clearly distinguishes them
from auras, but it also means that the identiﬁcation of PS in certain
patients provides a period of several hours for potential interven-
tions to avoid an impending seizure.
A signiﬁcant number of patients (50%) reported that prodromes
would not fade away until the seizure occurred, thus stressing their
pre-ictal character and suggesting the presence of a developing
process that ends up with a seizure.
It should be noticed that in some patients PS may begin even
earlier than our arbitrarily deﬁned 24-h time window.
4.3. Differentiating PS from seizures and from other peri-ictal
phenomena
Prodromal symptoms must be distinguished from auras, which
unequivocally belong to the seizure period. Consequently, the
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proﬁle helped us to clearly differentiate auras from PS, which
typically lasted several hours.
Furthermore, prodromal symptoms can usually be told apart
from seizure-precipitating factors. However, in some cases, such as
sleep disturbances, this differentiation may not be so easy,10 since
insomnia and sleep deprivation have a well-known role as seizure
precipitants. The fact that the most frequently reported sleep
change in our study was an increased somnolence (and most
patients actually slept more) made it easier to distinguish these
sleep changes from triggering factors. Similarly, behavioral
modiﬁcations, apart from acting as premonitory symptoms, could
either precipitate or inhibit seizures, according to the concept that
human epileptogenic brain may be behaviorally modulated.21–23
Therefore, it is likely that while sleep disturbances and behavioral
changes may express that a seizure is ‘‘building up’’, they could
alternatively or additionally facilitate seizure irruption.
PS can also be distinguished from prolonged seizures because
they have an insidious onset and their semiology is different from
that of the patient’s habitual seizures. However, complex partial
status or absence status could not be strictly ruled out in caseswith
behavioural or cognitive PS since we conducted no EEG recordings
during the prodromal phase. In this sense, EEG evidence of non-
convulsive status epilepticus has been found in two patients out of
ﬁve undergoing video-EEG from a group of 23 patients with
experiential epileptic prodromes.24 Therefore, this possibility
should be taken into account, at least in a small percentage of
patients reporting this type of prodromes.
Theoretically, it could be argued that some symptoms, here
characterized as prodromes, might correspond to side effects of
antiepileptic drugs. However, a crucial attribute of the symptoms
that were deﬁned as PS is that they were noticed only in the time
frame that preceded habitual seizures.
4.4. Limitations of the study
Our study has some limitations that must be taken into
consideration: (1) its design is retrospective, and although that is
valid for collecting the quality of pre-ictal symptoms, it is not
reliable enough to allow for sound conclusions regarding seizure
prediction. A prospective study would be required to assign
prodromes a truly predictive value; (2) we have found some
difﬁculties trying to deﬁne the temporal window for prodromes. In
this sense, there is no accepted pre-established time span. We
chose 24 h arbitrarily in order to enhance sensitivity using a
relatively wide frame, and to make it easier for the patients to
remember; (3) we were unable to determine duration of PS and
time elapsed to seizures more precisely, probably due to the
retrospective nature of the study.
4.5. Practical and therapeutic implications
Considering their prevalence and their potential value in
seizure anticipation, prodromal symptoms should be routinely
assessed in the anamnesis of epileptic patients in daily clinical
practice.
From a clinical perspective, the identiﬁcation of prodromal
symptoms, although less accurate than EEG algorithms in temporalterms, would offer a longer time window for a broader range of
therapeutic possibilities. Treatment modalities could then vary
from preventive measures, such as avoiding potentially risky
activities, to pharmacological or behavioral interventions. Further-
more, a deeper knowledge of the mechanisms underlying
prodromes may allow the design of speciﬁc ‘‘anti-ictogenic’’ drugs
and/or neurostimulation paradigms, capable of interrupting the
pre-ictal cascade.
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